Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart
| dc.contributor.author | Taliyan, Rajeev | |
| dc.date.accessioned | 2023-12-13T08:57:30Z | |
| dc.date.available | 2023-12-13T08:57:30Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | The signaling pathways upstream of glycogen synthase kinase-3β (GSK-3β) get reduced during ischemic preconditioning (IPC) in hyperlipidemic rat heart. Pioglitazone, an insulin sensitizer, exerts cardioprotection through GSK-3β. The objective of the study is to investigate the role of pioglitazone on the attenuated cardioprotective effect of IPC in hyperlipidemic rat heart. | en_US |
| dc.identifier.uri | https://www.ijp-online.com/article.asp?issn=0253-7613;year=2016;volume=48;issue=1;spage=59;epage=63;aulast=Mittal | |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13398 | |
| dc.language.iso | en | en_US |
| dc.publisher | Medknow | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Creatinine kinase | en_US |
| dc.subject | Glycogen synthase kinase-3β | en_US |
| dc.subject | Ischemia-reperfusion | en_US |
| dc.subject | Lactate dehydrogenase | en_US |
| dc.subject | Myocardial injury | en_US |
| dc.subject | Pioglitazone | en_US |
| dc.subject | Rapamycin | en_US |
| dc.subject | Wortmannin | en_US |
| dc.title | Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: